SK281405B6 - Terapeutický prípravok na transdermálnu aplikáciu účinných látok - Google Patents

Terapeutický prípravok na transdermálnu aplikáciu účinných látok Download PDF

Info

Publication number
SK281405B6
SK281405B6 SK558-98A SK55898A SK281405B6 SK 281405 B6 SK281405 B6 SK 281405B6 SK 55898 A SK55898 A SK 55898A SK 281405 B6 SK281405 B6 SK 281405B6
Authority
SK
Slovakia
Prior art keywords
active substances
skin
hmg
increase
therapeutic preparation
Prior art date
Application number
SK558-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK55898A3 (en
Inventor
Bodo Asmussen
Andreas Koch
Rudolf Matusch
Original Assignee
Lts Lohmann Therapie-Systeme Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Gmbh filed Critical Lts Lohmann Therapie-Systeme Gmbh
Publication of SK55898A3 publication Critical patent/SK55898A3/sk
Publication of SK281405B6 publication Critical patent/SK281405B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK558-98A 1995-11-06 1996-09-21 Terapeutický prípravok na transdermálnu aplikáciu účinných látok SK281405B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19541260A DE19541260A1 (de) 1995-11-06 1995-11-06 Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
PCT/EP1996/004138 WO1997017061A1 (de) 1995-11-06 1996-09-21 Therapeutische zubereitung zur transdermalen applikation von wirkstoffen durch die haut

Publications (2)

Publication Number Publication Date
SK55898A3 SK55898A3 (en) 1998-11-04
SK281405B6 true SK281405B6 (sk) 2001-03-12

Family

ID=7776710

Family Applications (1)

Application Number Title Priority Date Filing Date
SK558-98A SK281405B6 (sk) 1995-11-06 1996-09-21 Terapeutický prípravok na transdermálnu aplikáciu účinných látok

Country Status (21)

Country Link
US (1) US6379696B1 (zh)
EP (1) EP0859595B1 (zh)
JP (1) JP2001507331A (zh)
KR (1) KR100445940B1 (zh)
CN (1) CN1201385A (zh)
AT (1) ATE186209T1 (zh)
AU (1) AU716896B2 (zh)
CZ (1) CZ289143B6 (zh)
DE (2) DE19541260A1 (zh)
ES (1) ES2141534T3 (zh)
GR (1) GR3032523T3 (zh)
IL (1) IL124279A (zh)
MX (1) MX9803563A (zh)
MY (1) MY132407A (zh)
NO (1) NO982006D0 (zh)
NZ (1) NZ318783A (zh)
PL (1) PL326497A1 (zh)
PT (1) PT859595E (zh)
SK (1) SK281405B6 (zh)
WO (1) WO1997017061A1 (zh)
ZA (1) ZA969271B (zh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19830732B4 (de) * 1998-07-09 2008-11-13 Lts Lohmann Therapie-Systeme Ag Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung
CN100421653C (zh) * 2000-09-08 2008-10-01 阿尔扎公司 通过抑制通道关闭来抑制药物透皮通量减少的方法
US20020187169A1 (en) * 2001-05-11 2002-12-12 Shoujun Chen Kavalactone compositions
US7323191B2 (en) * 2003-07-28 2008-01-29 Alza Corporation Transdermal warfarin system
US20070166360A1 (en) * 2004-03-31 2007-07-19 Kowa Co., Ltd. External preparation
ES2385752T3 (es) * 2006-04-26 2012-07-31 Rosemont Pharmaceuticals Ltd Composiciones orales líquidas
US7803778B2 (en) 2006-05-23 2010-09-28 Theracos, Inc. Glucose transport inhibitors and methods of use
US8748419B2 (en) 2006-06-16 2014-06-10 Theracos, Inc. Treating obesity with muscarinic receptor M1 antagonists
US7893053B2 (en) 2006-06-16 2011-02-22 Theracos, Inc. Treating psychological conditions using muscarinic receptor M1 antagonists
US7652767B2 (en) * 2006-10-19 2010-01-26 Sporian Microsystems, Inc. Optical sensor with chemically reactive surface
US20080152592A1 (en) * 2006-12-21 2008-06-26 Bayer Healthcare Llc Method of therapeutic drug monitoring
US20100210932A1 (en) * 2007-03-20 2010-08-19 Bayer Healthcare Llc Method of analyzing an analyte
EP2064222B1 (en) 2007-04-02 2014-05-07 Theracos, Inc. Benzylic glycoside derivatives and methods of use
AU2008288770B2 (en) 2007-08-23 2014-06-12 Theracosbio, Llc Benzylbenzene derivatives and methods of use
BRPI0916769A2 (pt) 2008-07-15 2017-09-26 Theracos Inc derivados de benzilbenzeno deuterados e métodos de uso
HUE029970T2 (en) 2008-08-22 2017-04-28 Theracos Sub Llc Method for producing SGLT2 inhibitors
CA2744498C (en) 2008-11-25 2017-10-24 University Of Rochester Mlk inhibitors and methods of use
WO2010150100A1 (en) 2009-06-24 2010-12-29 Entarco Sa The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer
WO2011130455A1 (en) 2010-04-13 2011-10-20 Najib Babul Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
EP2576549A4 (en) 2010-05-24 2013-12-18 Univ Rochester Bicyclic Heteroarylkinase Inhibitors and Methods of Use
WO2011153712A1 (en) 2010-06-12 2011-12-15 Theracos, Inc. Crystalline form of benzylbenzene sglt2 inhibitor
EP2654757A1 (en) 2010-12-22 2013-10-30 Entarco SA The use of spinosyns and spinosyn compositions as local anesthetics and as antiarrhythmic agents
EP2675893B1 (en) 2011-02-18 2019-01-09 The Scripps Research Institute Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
WO2014085795A1 (en) 2012-11-30 2014-06-05 University Of Rochester Mixed lineage kinase inhibitors for hiv/aids therapies
US9420820B2 (en) 2013-08-09 2016-08-23 University Of Tsukuba Method for isolating polyphenols from olive mill water
EP3119394B1 (en) 2014-03-19 2021-05-12 Curza Global LLC Compositions and methods comprising 2-(acylamino)imidazoles
WO2018184019A1 (en) 2017-03-31 2018-10-04 Curza Global, Llc Compositions and methods comprising substituted 2-aminoimidazoles
CN112638944A (zh) 2018-08-23 2021-04-09 西进公司 抗tigit抗体
TW202233248A (zh) 2020-11-08 2022-09-01 美商西健公司 組合療法
BR112023020662A2 (pt) 2021-04-09 2024-02-06 Seagen Inc Métodos de tratamento de câncer com anticorpos anti-tigit

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
US5211947A (en) * 1988-12-16 1993-05-18 Schering Corporation Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor
US5316765A (en) * 1989-09-07 1994-05-31 Karl Folkers Foundation For Biomedical And Clinical Research Use of coenzyme Q10 in combination with HMG-CoA reductase inhibitor therapies
ES2094809T3 (es) * 1990-03-30 1997-02-01 Yasunori Morimoto Composicion absorbible por via percutanea del clorhidrato de morfina.
IL109037A (en) * 1993-03-19 1999-01-26 Cellegy Pharma Inc Preparations for causing phase separation of lipid layers and preparation of the above preparations
DE4341444C2 (de) * 1993-12-04 1996-03-14 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung
US5968983A (en) * 1994-10-05 1999-10-19 Nitrosystems, Inc Method and formulation for treating vascular disease

Also Published As

Publication number Publication date
CN1201385A (zh) 1998-12-09
AU716896B2 (en) 2000-03-09
ATE186209T1 (de) 1999-11-15
MY132407A (en) 2007-10-31
KR100445940B1 (ko) 2005-09-30
ES2141534T3 (es) 2000-03-16
NO982006L (no) 1998-05-04
CZ289143B6 (cs) 2001-11-14
GR3032523T3 (en) 2000-05-31
EP0859595B1 (de) 1999-11-03
PT859595E (pt) 2000-04-28
MX9803563A (es) 1998-09-30
DE19541260A1 (de) 1997-05-07
US6379696B1 (en) 2002-04-30
NO982006D0 (no) 1998-05-04
JP2001507331A (ja) 2001-06-05
NZ318783A (en) 1999-04-29
DE59603597D1 (de) 1999-12-09
EP0859595A1 (de) 1998-08-26
SK55898A3 (en) 1998-11-04
WO1997017061A1 (de) 1997-05-15
AU7085996A (en) 1997-05-29
IL124279A (en) 2003-07-06
PL326497A1 (en) 1998-09-28
KR19990067320A (ko) 1999-08-16
ZA969271B (en) 1997-06-03
CZ136698A3 (cs) 1998-07-15

Similar Documents

Publication Publication Date Title
SK281405B6 (sk) Terapeutický prípravok na transdermálnu aplikáciu účinných látok
EP2521453B1 (en) Combinations of vitamin d and a statin for the treatment of migraine headaches
US8435556B2 (en) Transdermal delivery of cannabidiol
JP5184342B2 (ja) 外用の医薬組成物
JP5184341B2 (ja) 外用の医薬組成物
US4321257A (en) Potentiated medicaments
US4197318A (en) Potentiated antimicrobial medicaments
WO1997035576A1 (en) Use of isoniazid for the treatment of hyperlipoproteinemia
MXPA04009819A (es) Reduccion de crecimiento de vello.
KR100397361B1 (ko) 고중독성유기인신경독소,특히소만에의해야기되는중독의예방및예비치료를위한피소스티그민및스코폴아민의조합된경피투여를위한경피치료시스템및방법
US4474748A (en) Medicaments potentiated with phenyl alkanols
MXPA01000126A (es) Compuesto que contiene por lo menos un principio activo que incide en el indice de grasa en la sangre.
JP3040427B2 (ja) 神経痛治療用アスピリン含有軟膏組成物
WO2008129000A1 (en) Pyridopyrimidine derivatives and use thereof in the treatment of itch and itch related disorders
CA1072009A (en) Potentiated medicaments containing antimicrobial agents
EP2570123A1 (en) Use of 2,4-dichlorobenzyl alcohol having an anaesthetic effect
JP4630065B2 (ja) 外用剤
CA2038969A1 (en) Compositions comprising cytotoxic agent and permeation enhancers
US20190117585A1 (en) A device for the transdermal delivery of buprenorphine
CA2235617C (en) Therapeutic preparation for the transdermal administration of active substances
KR0176319B1 (ko) 알킬화제로 인한 피부 손상 치료용 조성물
AU9385098A (en) Intranasal formulation containing scopolamine and method of treating motion sickness
WO2009080301A1 (en) Treatment and prevention of ischaemic cerebral lesions and cerebrovascular cognitive impairment using a treatment regimen consisting of dipyridamole and an angiotensin ii receptor blocker in patients with previous stroke
CA3108911A1 (en) Compositions and methods for treatment of the side-effects associated with administration of therapeutic agents
JP3050917B2 (ja) 経皮投与基剤組成物とその薬剤組成物